POGO to NIH: Stop Academic Ghostwriting Pollution
Project on Government Oversight (POGO) asked NIH Director to take a firm stance against ghostwriting by academics who receive taxpayer funded grants.
Project on Government Oversight (POGO) asked NIH Director to take a firm stance against ghostwriting by academics who receive taxpayer funded grants.
An audit by Daniel Levinson, Inspector General of DHHS, confirms what has already been documented: that antipsychotics are widely misprescribed for unapproved uses and taxpayers are saddled with the high cost through Medicaid and Medicare.
The largest private global health foundations exert inordinate influence on public health policy–ensuring that those policies increase profits for their corporate and endowment portfolios.
“The law says veterans have the right to due process.But when the fiduciary process is initiated, that all goes out the window.”
"The world depends on 35% of those who are defiers–those who clearly see what is right and what is wrong. But they need to speak up, to protest, and to stand up for their ethical values. The future depends on you."
The FDA granted market exclusivity to KV for an old drug that had been available from special pharmacies that custom-compound treatments not approved by the FDA, for $20 a shot. By granting KV market exclusivity, women could no longer obtain the drug, Makena, at a reasonable price– KV set the price at $1,500 a shot.
A month after a report by a committee appointed by the National Academy of Sciences, at the request of the Justice Department, concluded that the scientific evidence implicating Bruce Ivins to the anthrax letter attacks was not definitive,The Los Angeles Times reports that a different report (also commissioned by the…
"The problem of prescription overdose in the military has its parallel in civilian life. The tragic overdose victims in both spheres represent canaries in the coal mine–only the most obvious victims of what has become our national orgy of over using psychotropic drugs." Allen Frances MD
This year alone, because of patent expirations, the drug industry will lose control over more than 10 megamedicines whose combined annual sales have neared $50 billion.
The deeper problem is that current incentives reward drug companies to develop mainly new, but not better medicines at ever higher prices.
Why did the BMJ fail to disclose its partnership agreement with Merck, major vaccine manufacturer–13 vaccines, including the controversial MMR vaccine ?
America’s health care expenditure is about to go through the roof–without improving anyone’s health!